Back to mobile site

Achillion Pharma (ACHN) Reports In-Line Q2 EPS

August 8, 2017 4:04 PM EDT

Achillion Pharma (NASDAQ: ACHN) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings